-
Je něco špatně v tomto záznamu ?
Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia
M. Soomann, V. Bily, M. Elgizouli, D. Kraemer, G. Akgül, H. von Bernuth, M. Bloomfield, N. Brodszki, F. Candotti, E. Förster-Waldl, T. Freiberger, M. Giżewska, A. Klocperk, U. Kölsch, KE. Nichols, R. Krüger, N. Oak, M. Pac, S. Prader, K....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
- MeSH
- agamaglobulinemie * genetika imunologie diagnóza MeSH
- B-lymfocyty imunologie MeSH
- dítě MeSH
- fenotyp * MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- Check Tag
- dítě MeSH
- kojenec MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- předškolní dítě MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
BACKGROUND: Agammaglobulinemia due to variants in IGLL1 has traditionally been considered an exceedingly rare form of severe B-cell deficiency, with only 8 documented cases in the literature. Surprisingly, the first agammaglobulinemic patient identified by newborn screening (NBS) through quantification of kappa-deleting recombination excision circles harbored variants in IGLL1. OBJECTIVE: We comprehensively reviewed clinical and immunologic findings of patients with B-cell deficiency attributed to variants in IGLL1. METHODS: NBS programs reporting the use of kappa-deleting recombination excision circle assays, the European Society for Immunodeficiencies Registry, and authors of published reports featuring patients with B-cell deficiency linked to IGLL1 variants were contacted. Only patients with (likely) pathogenic variants, reduced CD19+ counts, and no alternative diagnosis were included. RESULTS: The study included 13 patients identified through NBS, 2 clinically diagnosed patients, and 2 asymptomatic siblings. All had severely reduced CD19+ B cells (< 0.1 × 109/L) at first evaluation, yet subsequent follow-up assessments indicated residual immunoglobulin production. Specific antibody responses to vaccine antigens varied, with a predominant reduction observed during infancy. Clinical outcomes were favorable with IgG substitution. Two patients successfully discontinued substitution therapy without developing susceptibility to infections and while maintaining immunoglobulin levels. The pooled incidence of homozygous or compound heterozygous pathogenic IGLL1 variants identified by NBS in Austria, Czechia, and Switzerland was 1.3:100,000, almost double of X-linked agammaglobulinemia. CONCLUSION: B-cell deficiency resulting from IGLL1 variants appears to be more prevalent than initially believed. Despite markedly low B-cell counts, the clinical course in some patients may be milder than reported in the literature so far.
Berlin Institute of Health at Charité Universitätsmedizin Berlin Berlin Germany
Childrens' Hospital Skåne University Hospital Lund Sweden
Department of Allergy and Immunology The Children's Hospital at Westmead Sydney Australia
Department of Clinical Genetics University Hospital Copenhagen Copenhagen Denmark
Department of Human Genetics Labor Berlin Charité Vivantes GmbH Berlin Germany
Department of Immunology Labor Berlin Charité Vivantes GmbH Berlin Germany
Department of Immunology The Children's Memorial Health Institute Warsaw Poland
Department of Oncology St Jude Children's Research Hospital Memphis Tenn
Department of Pediatrics and Adolescent Medicine Rigshospitalet Copenhagen Denmark
Institute of Medical Genetics University of Zurich Zurich Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003701
- 003
- CZ-PrNML
- 005
- 20250206104627.0
- 007
- ta
- 008
- 250121s2024 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jaci.2024.08.002 $2 doi
- 035 __
- $a (PubMed)39147326
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Soomann, Maarja $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: Maarja.Soomann@kispi.uzh.ch
- 245 10
- $a Variants in IGLL1 cause a broad phenotype from agammaglobulinemia to transient hypogammaglobulinemia / $c M. Soomann, V. Bily, M. Elgizouli, D. Kraemer, G. Akgül, H. von Bernuth, M. Bloomfield, N. Brodszki, F. Candotti, E. Förster-Waldl, T. Freiberger, M. Giżewska, A. Klocperk, U. Kölsch, KE. Nichols, R. Krüger, N. Oak, M. Pac, S. Prader, K. Schmiegelow, A. Šedivá, G. Sogkas, A. Stittrich, UK. Stoltze, K. Theodoropoulou, K. Wadt, M. Wong, M. Zeyda, J. Pachlopnik Schmid, J. Trück
- 520 9_
- $a BACKGROUND: Agammaglobulinemia due to variants in IGLL1 has traditionally been considered an exceedingly rare form of severe B-cell deficiency, with only 8 documented cases in the literature. Surprisingly, the first agammaglobulinemic patient identified by newborn screening (NBS) through quantification of kappa-deleting recombination excision circles harbored variants in IGLL1. OBJECTIVE: We comprehensively reviewed clinical and immunologic findings of patients with B-cell deficiency attributed to variants in IGLL1. METHODS: NBS programs reporting the use of kappa-deleting recombination excision circle assays, the European Society for Immunodeficiencies Registry, and authors of published reports featuring patients with B-cell deficiency linked to IGLL1 variants were contacted. Only patients with (likely) pathogenic variants, reduced CD19+ counts, and no alternative diagnosis were included. RESULTS: The study included 13 patients identified through NBS, 2 clinically diagnosed patients, and 2 asymptomatic siblings. All had severely reduced CD19+ B cells (< 0.1 × 109/L) at first evaluation, yet subsequent follow-up assessments indicated residual immunoglobulin production. Specific antibody responses to vaccine antigens varied, with a predominant reduction observed during infancy. Clinical outcomes were favorable with IgG substitution. Two patients successfully discontinued substitution therapy without developing susceptibility to infections and while maintaining immunoglobulin levels. The pooled incidence of homozygous or compound heterozygous pathogenic IGLL1 variants identified by NBS in Austria, Czechia, and Switzerland was 1.3:100,000, almost double of X-linked agammaglobulinemia. CONCLUSION: B-cell deficiency resulting from IGLL1 variants appears to be more prevalent than initially believed. Despite markedly low B-cell counts, the clinical course in some patients may be milder than reported in the literature so far.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a agamaglobulinemie $x genetika $x imunologie $x diagnóza $7 D000361
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a fenotyp $7 D010641
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a B-lymfocyty $x imunologie $7 D001402
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bily, Viktor $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation Brno and Medical Faculty, Masaryk University, Brno, Czechia
- 700 1_
- $a Elgizouli, Magdeldin $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Kraemer, Dennis $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Akgül, Gülfirde $u Institute of Medical Genetics, University of Zurich, Zurich, Switzerland
- 700 1_
- $a von Bernuth, Horst $u Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine, University Hospital Center, Berlin, Germany; Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany; Department of Immunology, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin-Brandenburg Center for Regenerative Therapies, Berlin, Germany
- 700 1_
- $a Bloomfield, Markéta $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Brodszki, Nicholas $u Childrens' Hospital, Skåne University Hospital, Lund, Sweden
- 700 1_
- $a Candotti, Fabio $u Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Förster-Waldl, Elisabeth $u Department of Paediatrics and Adolescent Medicine, Division of Neonatology, Neuropaediatrics, and Paediatric Intensive Care and Center for Congenital Immunodeficiencies and Jeffrey Modell Diagnostic & Research Center, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Freiberger, Tomas $u Molecular Genetics Laboratory, Centre for Cardiovascular Surgery and Transplantation Brno and Medical Faculty, Masaryk University, Brno, Czechia
- 700 1_
- $a Giżewska, Maria $u Department of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases, and Cardiology of the Developmental Age, Pomeranian Medical University in Szczecin, Szczecin, Poland
- 700 1_
- $a Klocperk, Adam $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Kölsch, Uwe $u Department of Immunology, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany
- 700 1_
- $a Nichols, Kim E $u Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn
- 700 1_
- $a Krüger, Renate $u Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Department of Pediatric Respiratory Medicine, Immunology, and Critical Care Medicine, University Hospital Center, Berlin, Germany
- 700 1_
- $a Oak, Ninad $u Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn
- 700 1_
- $a Pac, Małgorzata $u Department of Immunology, The Children's Memorial Health Institute, Warsaw, Poland
- 700 1_
- $a Prader, Seraina $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Schmiegelow, Kjeld $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Šedivá, Anna $u Department of Immunology, 2nd Faculty of Medicine, Charles University and University Hospital in Motol, Prague, Czechia
- 700 1_
- $a Sogkas, Georgios $u Department of Rheumatology and Immunology, Hannover Medical University, and Hannover Medical School, Hannover, Germany
- 700 1_
- $a Stittrich, Anna $u Department of Human Genetics, Labor Berlin-Charité Vivantes GmbH, Berlin, Germany
- 700 1_
- $a Stoltze, Ulrik Kristoffer $u Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark
- 700 1_
- $a Theodoropoulou, Katerina $u Unit of Pediatric Immunology, Allergology and Rheumatology, Department of Woman, Mother, Child, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland
- 700 1_
- $a Wadt, Karin $u Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Genetics, University Hospital Copenhagen, Copenhagen, Denmark
- 700 1_
- $a Wong, Melanie $u Department of Allergy and Immunology, The Children's Hospital at Westmead, Sydney, Australia
- 700 1_
- $a Zeyda, Maximillian $u Department of Pediatrics and Adolescent Medicine, Austrian Newborn Screening, Clinical Division of Pediatric Pulmonology, Allergology and Endocrinology, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Pachlopnik Schmid, Jana $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
- 700 1_
- $a Trück, Johannes $u Division of Immunology and the Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland
- 773 0_
- $w MED00002505 $t Journal of allergy and clinical immunology $x 1097-6825 $g Roč. 154, č. 5 (2024), s. 1313-1324.e7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39147326 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104623 $b ABA008
- 999 __
- $a ok $b bmc $g 2263456 $s 1239708
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 154 $c 5 $d 1313-1324.e7 $e 20240813 $i 1097-6825 $m Journal of allergy and clinical immunology $n J Allergy Clin Immunol $x MED00002505
- LZP __
- $a Pubmed-20250121